The Valley Desk

NCT02286817 · Interventional trial

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder

Overall registry status Completed

Phase 1

Conditions Attention-deficit Hyperactivity Disorder (ADHD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov